Illuminating the Path to Commercial Success.

Strategic Guidance for Life Sciences Most Critical Decisions

High-touch strategic advisory and fractional C-suite leadership for life sciences innovators navigating capital formation, commercial launches, business development, and critical growth inflection points.

Stat Strip
30 Years Experience • 15+ Product Launches • $2B+ Revenue Generated •  $100M+ P&L Managed

Illuminating the Path to Commercial Success.

Strategic Guidance for Life Sciences Most Critical Decisions

High-touch strategic advisory helping life sciences innovators and executives navigate key inflection points, market complexities, and strategic exits.

Stat Strip
30 Years Experience • 15+ Product Launches • $2B+ Revenue Generated •  $100M+ P&L Managed

Illuminating the Path to Commercial Success.

Strategic Guidance for Life Sciences Most Critical Decisions

High-touch strategic advisory helping life sciences innovators and executives navigate key inflection points, market complexities, and strategic exits.

Stat Strip
30 Years Experience • 15+ Product Launches • $2B+ Revenue Generated •  $100M+ P&L Managed

Illuminating the Path to Commercial Success.

Strategic Guidance for Life Sciences Most Critical Decisions

High-touch strategic advisory helping life sciences innovators and executives navigate key inflection points, market complexities, and strategic exits.

Stat Strip
30 Years Experience • 15+ Product Launches • $2B+ Revenue Generated •  $100M+ P&L Managed
Capital Formation
Business Development
Commercial Launch
Fractional Leadership

Trusted by leading Biotech & Biopharma Organizations

Experience That Guides Critical Decisions

Illuminations Strategy Group brings senior executive leadership built on 30 years across pharma, biotech, medical devices, and diagnostics — combining a rare attribute most advisors don’t deliver: strategic architect and operational executor.

From seed financing through commercial launch, from in-licensing negotiations to board-level investor communications, ISG delivers the high-touch advisory life sciences leaders need at their most consequential moments.


We’ve built commercial organizations from inception, led 15+ product launches generating $2B+ in cumulative revenue, and guided companies through the full spectrum of growth inflection points by connecting corporate vision to investor confidence to market execution.

What strategic challenge are you facing?

Capital Raise & Investor Relations
Business Development & In-Licensing
Market Access & Pricing
Fractional C-Suite Leadership
Board & Investor Communications
Commercial Organization Build
Commercial Launch Strategy
Launch Readiness
Partnership Structuring

Strategic Impact Across Critical Inflection Points

See how strategic guidance has helped life sciences companies navigate complexity, unlock growth, and prepare for critical milestones — from seed-stage capital raises to first-in-class product launches and global commercial expansion.

MedNova Technologies

150+

Commercial team built

$100M+

P&L managed

First-in-Class

Product launched

Read The Story

RareCure Therapeutics

150+

Commercial team built

$100M+

P&L managed

First-in-Class

Product launched

Read The Story

SpecialtyRx Partners

150+

Commercial team built

$100M+

P&L managed

First-in-Class

Product launched

Read The Story

Global Health Solutions

150+

Commercial team built

$100M+

P&L managed

First-in-Class

Product launched

Read The Story

Biotech Startup Accelerates Commercial Strategy for Market Launch

15+ launches supported

$2B+ potential commercial value unlocked

12  months from strategy to launch readiness value unlocked

Read The Story

Medical Device Innovator: Seed Close + $10M Convertible Note Bridge

15+ launches supported

$2B+ potential commercial value unlocked

12  months from strategy to launch readiness value unlocked

Read The Story

Rare Disease Specialty Pharma: Four-Therapy In-Licensing

15+ launches supported

$2B+ potential commercial value unlocked

12  months from strategy to launch readiness value unlocked

Read The Story

Global Specialty Pharma: First Commercial Asset Launch + Digital Medicine Platform

15+ launches supported

$2B+ potential commercial value unlocked

12  months from strategy to launch readiness value unlocked

Read The Story

Strategic Advisory for Life Sciences at Critical Inflection Points

High-touch strategic guidance to help life sciences innovators and executives navigate market complexities, align stakeholders, and make confident decisions across the product and company lifecycle.

Fractional C-Suite Leadership

Embedded executive leadership — Fractional CCO, CBO, or CMO — for life sciences companies that need senior commercial firepower without a full-time hire. Engagements include leading a $10M capital raise for a medical device innovator; structuring specialty therapy in-licensing deals for a rare disease company; and commercialization strategy and execution.

Strategic Advisory & Project Work

Defined-scope engagements for specific inflection points — capital raises, launch planning, in-licensing diligence, partner identification, market access strategy, and commercial organization design. Structured as a primary scope with additional workstreams available as needs evolve.

Capital Formation & Investor Relations

Seed through Series C support, convertible note bridges, board and investor communications, and capital structure narratives that align commercial strategy with funding milestones.

Critical Inflection Point Planning

Strategic guidance through the moments that define enterprise value — first launch, partnership negotiations, market expansion, organizational scale-up, and capital events. Anticipate challenges, evaluate options, and position for sustainable growth.

Who We Support Across the Life Sciences Ecosystem

We work with founders, executives, and investors across pharma, biotech, medical devices, and diagnostics — bringing seasoned commercial leadership to the strategic decisions that define enterprise value.

Pre-Launch Readiness: Building Commercial Infrastructure Before Approval

The commercial organization you build before approval determines what your launch looks like the day after. Why pre-launch infrastructure decisions are the highest-leverage commercial work in life sciences — and what to prioritize when timeline and capital are both constrained.

15+ Product launches led
|
$2B+ Revenue generated across launches
View All Insights
Market Access Integration: Why It Belongs in Commercial Planning, Not Beside It

Market access decisions made independently of commercial strategy compound into commercial problems at launch. How to integrate market access into commercial planning from the start.

15+ Product launches led
|
$2B+ Revenue generated across launches
View All Insights
Board-Level Commercial Reporting: What Investors Actually Want to See

How commercial reporting should be structured for board and investor audiences — and the most common ways commercial leaders get this wrong.

15+ Product launches led
|
$2B+ Revenue generated across launches
View All Insights
Building a 150-Person Commercial Organization From Three

Practical lessons from scaling a commercial organization from inception through first-in-class launch — function by function, hire by hire.

15+ Product launches led
|
$2B+ Revenue generated across launches
View All Insights
In-Licensing Strategy: Diligence Beyond the Term Sheet

The commercial diligence questions that materially affect in-licensing outcomes — and the questions term-sheet-driven diligence often misses.

15+ Product launches led
|
$2B+ Revenue generated across launches
View All Insights
Fractional vs. Full-Time CCO: Choosing the Right Commercial Leadership Structure

When fractional commercial leadership is the right answer, when it isn’t, and how to structure either engagement for outcomes that compound.

15+ Product launches led
|
$2B+ Revenue generated across launches
View All Insights

Who We Support Across the Life Sciences Ecosystem

We work with innovators, investors, and executives across the life sciences ecosystem to bring seasoned perspective to market complexities and critical strategic decisions.

Innovators & Founders

High-touch advisory across capital formation, commercial strategy, business development, and investor messaging — supporting growth from seed through commercial launch.

15+Product launches led
$2B+Revenue generated across launches

Life Sciences Executives

Senior leadership support for portfolio strategy, commercial organization design, launch readiness, and the operational execution behind strategic decisions.

30 YearsAcross life sciences
150+Commercial team built from inception

Investors & Boards

Strategic evaluation of life sciences assets and commercial diligence to inform investment decisions, board discussions, and portfolio company support.

$100M+P&L managed across executive roles
Board-LevelDirect investor and BoD communications

Innovators & Founders

High-touch strategic advisory across corporate strategy, market positioning, business development, and investor messagingsupporting growth and key inflection points.

15+Product launches supported
$3B+Of commercial value unlocked through strategic planning

Life Sciences Executives

Senior leadership support for portfolio strategy, commercial organization design, launch readiness, and the operational execution behind strategic decisions.

30 YearsAcross life sciences
150+Commercial team built from inception

Investors & Boards

Strategic evaluation of life sciences assets and commercial diligence to inform investment decisions, board discussions, and portfolio company support.

$100M+P&L managed across executive roles
Board-LevelDirect investor and BoD communications

Proven Strategic Guidance With Measurable Impact

Senior executive leadership built on 30 years in life sciences — supporting innovators across capital formation, product launches, and growth inflection points.

30Years

Across pharma, biotech, medical devices, and diagnostics — anchored by a decade-plus in senior executive roles.

$2B+Revenue

Cumulative revenue generated across product launches.

15+Launches

Successful therapeutic and medical device launches across neurology, oncology, cardiology, women’s health, urology, infectious disease, dermatology, and rare disease.

90+Team Built

Commercial organization scaled from inception during executive tenure.